{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fraisinghealth.simplecast.com%2Fepisodes%2Fgoing-to-market-b2c2b-l_QOT7sj","width":444,"version":"1.0","type":"rich","title":"Going to Market in Healthcare: B2C2B","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/8bfdd457-9cd9-4577-bbed-a027587c6960/103ea12d-dd5b-4ef8-b398-ddf54dfbe24e/cover-art-3000x3000-no-grain-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/7e0694ca-dec6-43e6-9388-de2ec0454a5f\" height=\"200\" width=\"100%\" title=\"Going to Market in Healthcare: B2C2B\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, talk to Kate Ryder, founder and CEO of Maven; Amanda Rees, cofounder and CEO of Bold Health; and Bill Porter, VP and GM, International, of Butterfly Network, about their B2C2B go-to-market motion."}